FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968006530> ?p ?o ?g. }

• W1968006530 endingPage "341" @default.
• W1968006530 startingPage "336" @default.
• W1968006530 abstract "Investigations in dogs have shown substantial dexmedetomidine (Dex)-induced reductions in cerebral blood flow (CBF) unaccompanied by reductions in cerebral metabolic rate (CMR). If this effect were to occur in humans in areas of injured brain in which CBF is already low, oxygen delivery might be critically impaired. The institutional use of brain PO2 monitoring during neurovascular surgery and the use of Dex as a component of the anesthetic allowed insight into this issue. Data from 5 neurovascular surgery patients, 2 for excision of arteriovenous malformations (AVMs), and 3 for intracranial aneurysm clipping were reviewed retrospectively. All had acute, lesion-related neurologic deficits. During general anesthesia with sufentanil and sevoflurane, with or without N2O, a parenchymal brain tissue PO2 (PbrO2) electrode was placed directly in the territory at risk from the pending neurosurgical intervention. After a stable PbrO2 value was achieved, Dex was administered by bolus (1 μg/kg over 10 min) and infusion (0.5 to 0.7 μg/kg/min). Mean arterial pressure (MAP), heart rate (HR), and PbrO2 were observed continuously for at least 25 minutes. Baseline PbrO2 values were relatively low (≤16 mm Hg) in 4 of the 5 patients, a pattern consistent with antecedent neurologic insult. In the 15 minutes after initiation of Dex administration, the pattern was one of a modest increase in Pbr02 (maximum 11.1%; P=0.0147) occurring roughly in parallel with a modest increase in MAP [maximum 3.5 mm Hg (4.5%); P=0.041]. HR did not change. Clinically significant reduction of PbrO2 did not occur before neurosurgical interventions. These observations provide no support for a direct cerebral vasoconstrictive effect of Dex in humans that is independent of any vasoconstriction that may occur as a consequence of Dex-induced reduction in CMR. At a minimum, any such effect was insufficient to have an adverse effect on oxygen delivery to brain parenchyma." @default.
• W1968006530 created "2016-06-24" @default.
• W1968006530 creator A5055810350 @default.
• W1968006530 creator A5069352186 @default.
• W1968006530 date "2010-10-01" @default.
• W1968006530 modified "2023-09-23" @default.
• W1968006530 title "Brain Tissue Oxygenation During Dexmedetomidine Administration in Surgical Patients With Neurovascular Injuries" @default.
• W1968006530 cites W1513375223 @default.
• W1968006530 cites W1824630048 @default.
• W1968006530 cites W1967333047 @default.
• W1968006530 cites W1975423942 @default.
• W1968006530 cites W1977124221 @default.
• W1968006530 cites W1989682145 @default.
• W1968006530 cites W1991407090 @default.
• W1968006530 cites W1991573157 @default.
• W1968006530 cites W1998669709 @default.
• W1968006530 cites W2002407947 @default.
• W1968006530 cites W2018790554 @default.
• W1968006530 cites W2020449518 @default.
• W1968006530 cites W2022746025 @default.
• W1968006530 cites W2031981004 @default.
• W1968006530 cites W2036370342 @default.
• W1968006530 cites W2036459401 @default.
• W1968006530 cites W2041791214 @default.
• W1968006530 cites W2044296753 @default.
• W1968006530 cites W2045646024 @default.
• W1968006530 cites W2052347649 @default.
• W1968006530 cites W2077067643 @default.
• W1968006530 cites W2083186813 @default.
• W1968006530 cites W2084511325 @default.
• W1968006530 doi "https://doi.org/10.1097/ana.0b013e3181e4b7e3" @default.
• W1968006530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20622684" @default.
• W1968006530 hasPublicationYear "2010" @default.
• W1968006530 type Work @default.
• W1968006530 sameAs 1968006530 @default.
• W1968006530 citedByCount "30" @default.
• W1968006530 countsByYear W19680065302012 @default.
• W1968006530 countsByYear W19680065302013 @default.
• W1968006530 countsByYear W19680065302014 @default.
• W1968006530 countsByYear W19680065302016 @default.
• W1968006530 countsByYear W19680065302017 @default.
• W1968006530 countsByYear W19680065302018 @default.
• W1968006530 countsByYear W19680065302019 @default.
• W1968006530 countsByYear W19680065302020 @default.
• W1968006530 countsByYear W19680065302022 @default.
• W1968006530 countsByYear W19680065302023 @default.
• W1968006530 crossrefType "journal-article" @default.
• W1968006530 hasAuthorship W1968006530A5055810350 @default.
• W1968006530 hasAuthorship W1968006530A5069352186 @default.
• W1968006530 hasConcept C105572291 @default.
• W1968006530 hasConcept C126322002 @default.
• W1968006530 hasConcept C138885662 @default.
• W1968006530 hasConcept C141071460 @default.
• W1968006530 hasConcept C157767197 @default.
• W1968006530 hasConcept C2776277131 @default.
• W1968006530 hasConcept C2776452961 @default.
• W1968006530 hasConcept C2776814716 @default.
• W1968006530 hasConcept C2776848632 @default.
• W1968006530 hasConcept C2777953023 @default.
• W1968006530 hasConcept C2778162923 @default.
• W1968006530 hasConcept C2780954326 @default.
• W1968006530 hasConcept C2781302539 @default.
• W1968006530 hasConcept C41895202 @default.
• W1968006530 hasConcept C42219234 @default.
• W1968006530 hasConcept C43376680 @default.
• W1968006530 hasConcept C70289976 @default.
• W1968006530 hasConcept C71924100 @default.
• W1968006530 hasConcept C84393581 @default.
• W1968006530 hasConceptScore W1968006530C105572291 @default.
• W1968006530 hasConceptScore W1968006530C126322002 @default.
• W1968006530 hasConceptScore W1968006530C138885662 @default.
• W1968006530 hasConceptScore W1968006530C141071460 @default.
• W1968006530 hasConceptScore W1968006530C157767197 @default.
• W1968006530 hasConceptScore W1968006530C2776277131 @default.
• W1968006530 hasConceptScore W1968006530C2776452961 @default.
• W1968006530 hasConceptScore W1968006530C2776814716 @default.
• W1968006530 hasConceptScore W1968006530C2776848632 @default.
• W1968006530 hasConceptScore W1968006530C2777953023 @default.
• W1968006530 hasConceptScore W1968006530C2778162923 @default.
• W1968006530 hasConceptScore W1968006530C2780954326 @default.
• W1968006530 hasConceptScore W1968006530C2781302539 @default.
• W1968006530 hasConceptScore W1968006530C41895202 @default.
• W1968006530 hasConceptScore W1968006530C42219234 @default.
• W1968006530 hasConceptScore W1968006530C43376680 @default.
• W1968006530 hasConceptScore W1968006530C70289976 @default.
• W1968006530 hasConceptScore W1968006530C71924100 @default.
• W1968006530 hasConceptScore W1968006530C84393581 @default.
• W1968006530 hasIssue "4" @default.
• W1968006530 hasLocation W19680065301 @default.
• W1968006530 hasLocation W19680065302 @default.
• W1968006530 hasOpenAccess W1968006530 @default.
• W1968006530 hasPrimaryLocation W19680065301 @default.
• W1968006530 hasRelatedWork W2046103402 @default.
• W1968006530 hasRelatedWork W2360561850 @default.
• W1968006530 hasRelatedWork W2371040205 @default.
• W1968006530 hasRelatedWork W3011242126 @default.
• W1968006530 hasRelatedWork W3028389065 @default.
• W1968006530 hasRelatedWork W3032230163 @default.

• next